Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Mineral And Bone Disorder Treatment Market Expected To Expand Between 2025 And 2029?
The mineral and bone disorder treatment market size has experienced significant growth over recent years. It is anticipated to expand from $3.3 billion in 2024 to $3.54 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.4%. This historical expansion can be linked to factors including chronic kidney disease, an aging populace, increased understanding of mineral and bone disorders, improved access to relevant treatments, and rising levels of disposable income.
The mineral and bone disorder treatment market is projected to experience substantial growth in the upcoming years. It is forecast to expand to $4.69 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period is primarily driven by an increasing need for treatments that enhance quality of life, a rising demand for personalized medicine, government investments in healthcare, and a greater awareness of the importance of early diagnosis. Significant trends expected in this period encompass progress in medical research, pharmaceutical innovations, the evolution of digital health, the development of biologic therapies, and the wider adoption of telehealth and remote monitoring.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12956&type=smp
Which Drivers Are Impacting The Mineral And Bone Disorder Treatment Market?
The growing elderly population is projected to fuel the expansion of the mineral and bone disorder treatment market moving forward. The elderly population refers to a demographic group consisting of individuals who are 65 years old or more. Older adults typically encounter a reduction in muscle and bone mass, which leads to weakness and a decrease in physical strength. Mineral and bone treatment offers benefits by helping to prevent age-associated changes in muscles, bones, and joints, strengthening bones, and decelerating the rate of bone loss. For example, in July 2024, data from the UK Parliament’s House of Commons Library, a UK-based government administration, indicated that in 2022, 12.7 million people in the UK, or 19% of the total population, were aged 65 or older. This figure is expected to increase to 22.1 million by 2072, constituting 27% of the population. Therefore, the expanding elderly population is a significant driver behind the growth of the mineral and bone disorder treatment market.
What Are The Major Segments Identified In The Mineral And Bone Disorder Treatment Market?
The mineral and bone disorder treatmentmarket covered in this report is segmented –
1) By Treatment: Diet; Nutrition; Medication; Supplements; Dialysis
2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Diet: Calcium-Rich Foods; Vitamin D-Enriched Foods; Phosphorus-Rich Foods
2) By Nutrition: Nutritional Counseling; Fortified Food Products; Meal Replacement Programs
3) By Medication: Bisphosphonates; Hormonal Therapies; RANK Ligand Inhibitors
4) By Supplements: Calcium Supplements; Vitamin D Supplements; Multivitamin Supplements
5) By Dialysis: Hemodialysis; Peritoneal Dialysis; Continuous Renal Replacement Therapy (CRRT)
Which Key Trends Are Expected To Influence The Mineral And Bone Disorder Treatment Market In The Coming Years?
Companies operating in the mineral and bone disorder treatment market are concentrating on developing new products and securing their approval to enhance their market standing. Drug approvals for mineral and bone conditions are experiencing an increase, driven by the aging population and the rising prevalence of chronic kidney diseases. A notable example is TYMLOS (abaloparatide), which contains the active drug abaloparatide, a synthesized (lab-made) form of the human parathyroid hormone. For instance, in December 2022, Radius Health Inc., a US-based biopharmaceutical company, obtained approval for TYMLOS (abaloparatide), a parathyroid hormone-related peptide [PTHrP(1-34)] analog, designated for increasing bone density in men with osteoporosis who are at a high risk of fracture. This treatment operates as an anabolic agent for the bone by selectively activating the parathyroid hormone 1 receptor (PTH1R) expressed in osteoblasts and osteocytes, which consequently leads to enhanced bone formation and density.
Which Major Industry Participants Are Leading The Mineral And Bone Disorder Treatment Market Growth?
Major companies operating in the mineral and bone disorder treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Co. Ltd., Eli Lilly And Company, Amgen Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Servier Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Cadila Healthcare Ltd., Alembic Pharmaceuticals Limited, Ajanta Pharma Ltd., Abiogen Pharma Spa, Melinta Therapeutics Inc., Intas Pharmaceuticals Ltd., Radius Health Inc., EffRx Pharmaceuticals SA.
Download The Full Report For Exclusive Market Findings:
How Does The Mineral And Bone Disorder Treatment Market Perform Across Key Geographic Regions?
North America was the largest region in the mineral and bone disorder treatment market in 2024. The regions covered in mineral and bone disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Mineral And Bone Disorder Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12956&type=smp
Browse Through More Reports Similar to the Global Mineral And Bone Disorder Treatment Market 2025, By The Business Research Company
Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Patient Blood Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Anemia And Other Blood Disorder Drugs Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model